Utah Medical Products (NASDAQ:UTMD) Stock Rating Upgraded by StockNews.com

Utah Medical Products (NASDAQ:UTMDGet Free Report) was upgraded by StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued on Wednesday.

Separately, TheStreet lowered Utah Medical Products from a “b-” rating to a “c+” rating in a research note on Monday, February 12th.

Check Out Our Latest Stock Report on UTMD

Utah Medical Products Stock Down 0.3 %

Shares of NASDAQ:UTMD traded down $0.22 on Wednesday, reaching $69.90. The company had a trading volume of 41,284 shares, compared to its average volume of 20,420. Utah Medical Products has a twelve month low of $69.41 and a twelve month high of $100.59. The stock has a 50-day moving average price of $78.97 and a 200 day moving average price of $83.01. The stock has a market capitalization of $253.74 million, a P/E ratio of 15.30 and a beta of 0.14.

Utah Medical Products (NASDAQ:UTMDGet Free Report) last announced its quarterly earnings results on Tuesday, January 30th. The medical instruments supplier reported $1.18 earnings per share for the quarter. Utah Medical Products had a return on equity of 13.73% and a net margin of 33.12%. The company had revenue of $12.33 million during the quarter.

Hedge Funds Weigh In On Utah Medical Products

Institutional investors have recently made changes to their positions in the business. Northwest Financial Advisors bought a new position in shares of Utah Medical Products in the fourth quarter worth about $25,000. Acadian Asset Management LLC bought a new position in Utah Medical Products during the first quarter valued at about $40,000. Legal & General Group Plc increased its stake in Utah Medical Products by 30.0% during the fourth quarter. Legal & General Group Plc now owns 615 shares of the medical instruments supplier’s stock valued at $52,000 after acquiring an additional 142 shares during the period. Osaic Holdings Inc. increased its stake in Utah Medical Products by 22.3% during the second quarter. Osaic Holdings Inc. now owns 646 shares of the medical instruments supplier’s stock valued at $60,000 after acquiring an additional 118 shares during the period. Finally, BNP Paribas Arbitrage SA increased its stake in Utah Medical Products by 97.7% during the second quarter. BNP Paribas Arbitrage SA now owns 779 shares of the medical instruments supplier’s stock valued at $67,000 after acquiring an additional 385 shares during the period. 70.35% of the stock is currently owned by institutional investors.

About Utah Medical Products

(Get Free Report)

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.

Read More

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.